Vape market statistics at a glance
The vape market sits in a strange middle ground: commercial growth, regulatory pressure, and a youth-use story that still drives the headline numbers. The supplied statistics show a category that is expanding in retail reach and consumer use while also facing heavy enforcement, changing product mix, and slower growth in some segments.
Table of contents
- Fast facts
- Vape market size and reach
- Youth usage and school-age trends
- Adult use and demographic splits
- Regulation and enforcement
- Company signals and category competition
- What the numbers suggest
Fast facts
Big number: 45 e-cigarettes are authorized for legal sale in the U.S. (FDA authorized e-cigarettes page).
Youth use: 5.9% of U.S. middle and high school students used e-cigarettes in the past 30 days in 2024, equal to 1.63 million students (CDC MMWR NYTS 2024).
Adult use: Adult e-cigarette use rose to 6.5% in 2023 from 4.5% in 2019 (CDC NCHS Data Brief 524).
Global scale: WHO estimated more than 100 million people worldwide currently vape, including 86.1 million adult e-cigarette users and 14.7 million adolescent e-cigarette users (WHO global tobacco trends report).
Vape market size and reach
The dataset points to a market defined less by one clean sales number and more by a set of proxy measures: regulatory authorizations, retail distribution, consumer counts, and category revenue.
One important signal is the size of the authorized U.S. product set. The FDA says there are 45 e-cigarettes authorized for legal sale in the U.S. (FDA authorized e-cigarettes page). That is a narrow legal universe compared with the broader market conversation, and it helps explain why enforcement remains central to the category.
The commercial side is still active. Altria said NJOY ACE distribution expanded to over 100,000 stores in 2024 (Altria 2024 annual report). It also said more than 80% of contracted stores received premium positioning for NJOY ACE in 2024 (Altria 2024 annual report). Those two figures matter because they show the market is not just about consumer demand; it is also about shelf space and retail access.
At the same time, the market mix is broader than cigarettes and e-cigarettes alone. The 2024 NYTS found among all middle and high school students that nicotine pouches were used by 1.8%, while cigarettes, cigars, smokeless tobacco, and other oral nicotine products were each at 1.2% or lower for several categories (CDC MMWR NYTS 2024). This suggests the nicotine market is fragmenting across formats rather than moving in one straight line.
Market signals you can track quickly
- Legal authorization is tight: 45 authorized e-cigarettes (FDA authorized e-cigarettes page).
- Retail distribution can still be large: over 100,000 stores for NJOY ACE (Altria 2024 annual report).
- Premium shelf placement is meaningful: over 80% of contracted stores (Altria 2024 annual report).
- Global use is still substantial: more than 100 million current vapers worldwide (WHO global tobacco trends report).
Youth usage and school-age trends
Youth use remains the most sensitive and closely watched part of the vape market. The latest NYTS data show both scale and recent improvement.
In 2024, 5.9% of U.S. middle and high school students used e-cigarettes in the past 30 days, equal to 1.63 million students (CDC MMWR NYTS 2024). That same survey found 8.1% of all middle and high school students used any tobacco product in the past 30 days, equal to 2.25 million students (CDC MMWR NYTS 2024). The difference matters: e-cigarettes are the largest share of current youth tobacco use, but they are not the only part of the picture.
The year-over-year movement is also notable. High school current tobacco use fell to 10.1% in 2024 from 12.6% in 2023 (CDC MMWR NYTS 2024). High school current e-cigarette use fell to 7.8% in 2024 from 10.0% in 2023 (CDC MMWR NYTS 2024). Across all students, current use of any tobacco product fell from 10.0% to 8.1%, and e-cigarette use fell from 7.7% to 5.9% from 2023 to 2024 (CDC MMWR NYTS 2024).
That is not just a percentage story. The estimated number of all students using any tobacco product fell by 550,000 from 2023 to 2024 (CDC MMWR NYTS 2024). High school e-cigarette users fell from 1.56 million to 1.21 million (CDC MMWR NYTS 2024).
Youth tobacco use comparison table
| Measure | 2023 | 2024 | Source |
|---|---|---|---|
| All students, any tobacco product | 10.0% | 8.1% | CDC MMWR NYTS 2024 |
| All students, e-cigarettes | 7.7% | 5.9% | CDC MMWR NYTS 2024 |
| High school, any tobacco product | 12.6% | 10.1% | CDC MMWR NYTS 2024 |
| High school, e-cigarettes | 10.0% | 7.8% | CDC MMWR NYTS 2024 |
| High school, cigarettes | not stated | 1.7% | CDC MMWR NYTS 2024 |
| Middle school, cigarettes | not stated | 1.1% | CDC MMWR NYTS 2024 |
A few youth-market points stand out:
- E-cigarettes have been the most used tobacco product among U.S. youths since 2014 (CDC MMWR NYTS 2024).
- 43.6% of students who had ever used e-cigarettes reported current e-cigarette use in 2024 (CDC MMWR NYTS 2024). That is a strong signal of persistence among ever-users.
- Among all students, nicotine pouches at 1.8% were the highest single non-combustible category listed after e-cigarettes in the dataset (CDC MMWR NYTS 2024).
- Flavored products remain central: 88.2% of high school students and 85.7% of middle school students who used e-cigarettes in the past 30 days used flavored e-cigarettes (CDC youth data page).
Why the youth data matters for the market
The youth numbers affect the vape market even when the question is commercial rather than public health. A category that faces repeated enforcement, flavor scrutiny, and retail compliance pressure will not behave like a normal consumer packaged goods segment.
The 2024 survey also gives a useful baseline for product hierarchy among students. Among all students in 2024, cigarettes were used by 1.4%, cigars by 1.2%, smokeless tobacco by 1.2%, other oral nicotine products by 1.2%, heated tobacco products by 0.8%, hookahs by 0.7%, and pipe tobacco by 0.5% (CDC MMWR NYTS 2024). E-cigarettes clearly remain the largest single youth nicotine format in this set.
Adult use and demographic splits
Adult data show a different pattern from youth data. The adult category is larger in absolute terms and appears to be moving more slowly, but it still has important growth in exclusive e-cigarette use.
CDC?s adult data brief says adult e-cigarette use rose from 4.5% in 2019 to 6.5% in 2023 (CDC NCHS Data Brief 524). The path in between was 3.7% in 2020, 4.5% in 2021, and 6.0% in 2022 (CDC NCHS Data Brief 524). That steady climb shows a market that is not just a youth story.
The strongest adult gains appear in younger adults. In 2023, adult e-cigarette use reached 15.5% among ages 21?24, 10.3% among ages 18?20, and 12.6% among ages 25?34 (CDC NCHS Data Brief 524). By contrast, it was 7.3% among ages 35?49, 3.3% among ages 50?64, and 0.9% among ages 65 and older (CDC NCHS Data Brief 524).
Adult e-cigarette use by group
| Group | 2023 adult e-cigarette use | Source |
|---|---|---|
| Men | 7.6% | CDC NCHS Data Brief 524 |
| Women | 5.5% | CDC NCHS Data Brief 524 |
| Ages 18?20 | 10.3% | CDC NCHS Data Brief 524 |
| Ages 21?24 | 15.5% | CDC NCHS Data Brief 524 |
| Ages 25?34 | 12.6% | CDC NCHS Data Brief 524 |
| Ages 35?49 | 7.3% | CDC NCHS Data Brief 524 |
| Ages 50?64 | 3.3% | CDC NCHS Data Brief 524 |
| Ages 65+ | 0.9% | CDC NCHS Data Brief 524 |
The demographic spread is also uneven by race and ethnicity. Adult e-cigarette use in 2023 was 7.5% among White non-Hispanic adults, 5.7% among Black non-Hispanic adults, 4.4% among Hispanic adults, 3.4% among Asian non-Hispanic adults, and 8.0% among other and multiple-race non-Hispanic adults (CDC NCHS Data Brief 524).
A broader long-run trend reinforces the point that e-cigarettes are not marginal among adults. The number of adults who used exclusive e-cigarettes rose from 2.9 million in 2017 to 10.1 million in 2023 (CDC MMWR adults 2017?2023). Exclusive e-cigarette use prevalence rose from 1.2% to 4.1% over the same period (CDC MMWR adults 2017?2023).
At the same time, exclusive cigarette smoking prevalence fell from 10.8% in 2017 to 7.9% in 2023, and the number of exclusive cigarette smokers fell from 26.6 million to 19.8 million (CDC MMWR adults 2017?2023). That does not prove one product displaced the other, but it does show the broader nicotine market is shifting.
Regulation and enforcement
No vape market analysis is complete without enforcement. The regulatory backdrop is not a side note; it is part of the market structure.
The FDA said it had issued more than 440 warning letters and 88 civil money penalties to retailers for illegal e-cigarette sales by January 30, 2024 (FDA warning-letters announcement). By July 25, 2024, the FDA said it had issued more than 690 warning letters and more than 140 civil money penalty actions to retailers for unauthorized e-cigarettes (FDA warning-letters announcement).
The agency also said it issued warning letters to 80 retailers in 15 states on July 25, 2024, for selling unauthorized Elf Bar and Lost Mary e-cigarettes (FDA warning-letters announcement). That gives a concrete sense of how enforcement is distributed across retail channels.
Another important enforcement figure: the FDA and DOJ seized more than $7 million worth of illegal e-cigarettes in a federal operation announced in 2024 (FDA seizure announcement). In a separate coordinated federal action in April 2024, the FDA said more than 45,000 unauthorized e-cigarettes valued at more than $3.0 million were seized (FDA enforcement report).
Enforcement snapshot
- 440+ warning letters and 88 civil money penalties by January 30, 2024 (FDA warning-letters announcement).
- 690+ warning letters and 140+ civil money penalty actions by July 25, 2024 (FDA warning-letters announcement).
- 80 retailers across 15 states targeted on July 25, 2024 (FDA warning-letters announcement).
- $7 million+ in illegal e-cigarettes seized in a federal operation in 2024 (FDA seizure announcement).
- 45,000+ unauthorized e-cigarettes valued at $3.0 million+ seized in April 2024 (FDA enforcement report).
This enforcement environment affects market access, product availability, and consumer substitution patterns. It also helps explain why some brands focus heavily on authorized products, retail partnerships, and premium placement.
Company signals and category competition
Company reporting gives another view of the vape market: not consumer prevalence, but how category players see demand and operational performance.
Altria?s 2024 report shows several key signals. It said on! shipment volume increased by more than 40% to 160 million cans in 2024 (Altria 2024 annual report). It also said on! reached 8.3% of the total U.S. oral tobacco category for full-year 2024 (Altria 2024 annual report). That is relevant because nicotine pouches are now part of the same competitive landscape as e-cigarettes for many consumers.
Altria also reported smokeable products adjusted OCI of $10.9 billion in 2024 and smokeable products adjusted OCI margins of 61.6% (Altria 2024 annual report). For oral tobacco, it reported adjusted OCI growth of 5.2% and adjusted OCI margins of 67.8% (Altria 2024 annual report). Those numbers show why nicotine categories remain strategically important even under regulatory pressure.
Marlboro still matters too. Altria said Marlboro?s share of the premium segment reached 59.3% in 2024 (Altria 2024 annual report). That is a reminder that the vape market does not exist in isolation; it competes with the cigarette market and with oral nicotine products for consumer attention and shelf space.
Altria also said it returned over $10.2 billion to shareholders in 2024 through dividends and share repurchases, raised its dividend for the 59th time in 55 years, and completed a $3.4 billion share repurchase program (Altria 2024 annual report). Those figures are corporate finance signals, but they matter because they show the business is still generating enough cash to fund both legacy and new-category activity.
BAT?s 2024 figures show a similarly mixed picture. It said Vapour value share of 40.0% in Top Vapour markets in 2024 (BAT FY2024 pre-close trading update). It also said Vapour was the largest contributor to New Category usage, reaching 11.9 million adult consumers in 2024 (BAT FY2024 preliminary announcement). BAT said four of its seven Top Vapour markets were profitable on a category contribution basis in 2024 (BAT FY2024 preliminary announcement).
But BAT also reported pressure in some regions. Vapour volume in AME declined 11.5% in 2024, and Vapour revenue in AME fell 10.8% (BAT 2024 annual report). It also said its overall Vapour revenue in 2024 was 5.6% lower in the annual report summary (BAT 2024 annual report). In contrast, it reported ?115 million in Vapour revenue in APMEA at constant currency, ?625 million in AME, and ?1,025 million in the Americas and Europe (AME) at constant currency (BAT FY2024 preliminary announcement).
Company-level comparison table
| Company / signal | 2024 figure | Source |
|---|---|---|
| Altria NJOY ACE distribution | over 100,000 stores | Altria 2024 annual report |
| Altria on! shipment volume | 160 million cans | Altria 2024 annual report |
| Altria on! share of U.S. oral tobacco | 8.3% | Altria 2024 annual report |
| BAT Vapour value share in Top Vapour markets | 40.0% | BAT FY2024 pre-close trading update |
| BAT New Category adult consumers | 11.9 million | BAT FY2024 preliminary announcement |
| BAT Top Vapour markets profitable | 4 of 7 | BAT FY2024 preliminary announcement |
What the numbers suggest
The supplied statistics point to a vape market with four simultaneous realities.
First, the category is still large and globally relevant. WHO estimates more than 100 million current vapers worldwide (WHO global tobacco trends report), which means this is no niche niche. It is a major nicotine segment with international weight.
Second, the U.S. youth story is improving but not resolved. Youth e-cigarette use fell in 2024, yet 5.9% of all middle and high school students still used e-cigarettes in the past 30 days, and flavored products remain dominant among student users (CDC MMWR NYTS 2024; CDC youth data page).
Third, adult use is concentrated in younger age groups. The 2023 adult data show the highest use among ages 21?24, 25?34, and 18?20 (CDC NCHS Data Brief 524). That pattern suggests the market?s growth profile is tied to younger adults more than to the overall population.
Fourth, regulatory enforcement is not peripheral. The FDA?s warning letters, penalties, and seizures are large enough to shape the legal and retail structure of the market itself (FDA warning-letters announcement; FDA seizure announcement; FDA enforcement report).
The strongest single takeaway is that the vape market is not moving in one direction. The data show falling youth prevalence, rising adult exclusive use, expanding retail distribution for some brands, and aggressive enforcement against unauthorized products. Any serious read of the category has to hold all four at once.